Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

Front Med (Lausanne). 2022 May 4:9:923790. doi: 10.3389/fmed.2022.923790. eCollection 2022.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.850858.].

Keywords: COVID-19; SARS-CoV-2; disease-modifying anti-rheumatic drugs; humoral response; rheumatic musculoskeletal diseases; risk of infection; seroprevalence.

Publication types

  • Published Erratum